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•	 There is a strong association between the presence of point mutation at the position of Ser83 and 
vancomycin resistant phenotype.
•	 Resistance in Enterococcus spp. is highly mediated by mutations in gyrA gene which plays a major role in 
interaction with vancomycin.
•	 Vancomycin is the only drug that can be consistently relied on for the treatment of infections caused by 
multidrug resistant enterococci.
•	 VRE has presented a serious challenge for the Iranian medical community.
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ABSTRACT
Enterococci are among Gram-positive cocci and are common inhabitants of the human 
gastrointestinal tract and enough potent to cause serious infections such as bacteremia, 
urinary tract infections (UTIs) and endocarditis. Enterococci are not generally considered 
as highly infectious bacterium. However, the main reason for treatment failure in 
enterococcal	 infections	 is	 acquired	 resistance	 to	 glycopeptide	 antibiotics,	 specifically	
vancomycin. Most enterococcal infections in human such as gastroenteritis, intestinal 
infections, and endocarditis have been caused by E. faecalis and E. facieum. They are 
holding the second place of most frequent cause of hospital infections since 1990. In 
present study gyrA S83R polymorphism rate in vancomycin resistant Enterococcus 
faecium isolated from environment, food industries, and hospitals of Tehran were 
examined by ARMS-PCR technique. DNA was extracted from the bacterial colonies 
using standard column method, after separating the samples into two groups of antibiotic 
resistant and antibiotic susceptible by antibiogram test. A fragment of gyrA gene was 
amplified	 using	 PCR	method	 to	 investigate	 point	mutation	 of	 S83R	 position.	ARMS-
PCR technique was applied to detect the presence or absence of mutation using a set 
of	 specified	primers	which	 can	be	 annealed	when	 the	mutation	 is	 present.	The	 results	
were statistically analyzed by chi-square test (p < 0.05) using SPSS 19th version. The 
results	 showed	 that	 there	was	a	 significant	 correlation	between	 the	presences	of	S83R	
polymorphism with vancomycin resistance trait in Entrococcus faecium. Therefore, this 
technique could be used as a diagnostic tool to detect vancomycin resistance cases of E. 
faecium in patients and environment.
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Introduction 
Enterococci have been recognized as a common cause 
of serious infections such as bacteremia diverticulitis, 
meningitis and endocarditis. They are most commonly 
isolated from infections of urinary tract, and wounds 
(French, 1998; Morandi et al., 2006; Brinster et al., 2007; 
Sood et al., 2008; Nallapareddy et al., 2011). 
The enterococci readily colonize the bowel, spread 
rapidly in nature, between healthcare employees or 
other industries and mostly can be transmitted from 
patient to patient in the hospitals (French, 1998; Woodford, 
1998; Rathnayake et al., 2012). Antibiotic resistance 
would be considered as an important risk factor for the 
elderlies. The enteroccocal infections may be treated 
with vancomycin, which is common medication used to 
reduce the symptoms of patients. However, vancomycin 
resistance	enterococci	(VRE)	infections	are	more	difficult	
to deal with, because the effective antibiotics against 
resistant bacteria are rare and the antibiotic resistant 
species can widely transfer among patients. As a result, 
the frequency of VRE infections is increasing (Cloete, 
2003; Hollenbeck and Rice, 2012). The great majority 
of enterococcal infections are caused by Enterococcus 
faecalis and Enterococcus faecium. 
Enterococcus faecalis is the most common isolate 
among enterococci. However, Enterococcus faecium has 
become increasingly important after the emergence of 
vancomycin resistance (Huycke et al., 1998; Weinstein 
and Hayden, 2000; Cloete, 2003; Fisher and Phillips, 
2009). 
The major cause of enterococcal infections is related 
to E. faecalis (Sood et al., 2008). E. faecium causes 
a substantial proportion of infections acquired in the 
hospital setting. In the late 1980s, clinical isolates of 
the vancomycin resistance enterococci species began to 
appear,	 which	 induced	 significant	 changes	 in	microbial	
identification	 of	 enterococci	 in	 the	 clinical	 laboratories	
and infection control units (Huycke et al., 1998; Murray, 
2000; Giraffa, 2002; Sood et al., 2008; Fisher and 
Phillips, 2009). The phenotypic and genotypic bases 
of several VRE have been characterized. E. faecium is 
equipped with a variety of inherent antibiotic-resistance 
genes as well as the acquired ones. Since many clinical 
isolates of E. faecium are resistant to vancomycin and 
fluoroquinolones,	there	are	very	limited	treatment	choice	
for E. faecium infections (Huycke et al., 1998; Weinstein 
and Hayden, 2000; Rice, 2006; Fisher and Phillips, 2009). 
Pathogen resistance to antibiotics can be the result 
of variations in drug target, molecular bypass, active 
efflux	 (or	 decreased	 entry),	 and	 chemical	 modification	
of the compound. Several antibiotics exert their growth 
inhibitory activity against bacteria through the interaction 
with critical bacterial pathways such as DNA synthesis. 
Therefore, alteration of the molecular targets are the 
basic mechanism of bacterial resistance (Wright, 2011). 
DNA gyrase (topoisomerase II) and topoisomerase IV 
(parC and parE) are the enzymes involved in DNA 
synthesis	 that	may	 be	modified	 in	 the	 resistant	 bacteria	
(Giedraitienė	et	al.,	2011).	The	genes	of	gyrA and gyrB 
are the relevant genes of DNA gyrase that their single 
mutations	 may	 emerge	 high	 level	 of	 flouroquinolone	
resistance in pathogenic gram positive bacteria; as the 
minor changes in the amino acid sequence of enzymes can 
alter the protein structure required for antibiotic binding 
and action. For example, mutation of Ser to an amino acid 
with a bulkier side chain (Leu, Trp, Ile) at position 83, or 
Asp87	to	Asn,	Tyr,	or	Gly	are	the	common	modifications	
resulted	 in	 fluoroquinolone	 resistant	 species	 (Wright,	
2011). Mutations of gyrA or parC are not directly relevant 
to the vancomycin mechanism of action but these 
mutations have been reported in VER species (López et 
al., 2011; Miller et al., 2014).
Recent studies have shown that in E. faecium, 
vancomycin resistance can be related to mutations in the 
gyrA gene. All common species comes with amino acid 
changes in gyrA protein (S83I, S83Y, S83R or S83I-
E87G) with/without changes in parC protein (S80I or 
S80R or S80l) (Korten et al., 1994; Morandi et al., 2006; 
Tenover, 2006; Rathnayake et al., 2011; Teymournejad et 
al., 2011; Ardebili et al., 2015). 
The origins of Enterococcus species have variation 
from environmental to animal and human sources. The 
distribution of Enterococcus species varies throughout 
Asia. In Iran E. faecalis and E. faecium are the most 
commonly isolated species from clinical, industrial, and 
environmental sources (Fatholahzadeh et al., 2006). 
In this study, we have analyzed vancomycin resistance 
E. faecium isolates from various origins (Giraffa, 2002; 
Moreno et al., 2006; Ogier and Serror, 2008), including 
environment, food industries and hospitals, for point 
mutation in gyrA at position 83 (serine-to-arginine 
substitutions).
Materials and Methods
Bacterial isolates and growth conditions
This research is a cross sectional and purely descriptive 
study which is carried out over a 13 month period (January 
to February 2016) in three origins; 
1. Hospitals (Besat Nahaja General Hospital,  Laleh 
Hospital), 2. Environment (Tajrish -Shemiranat river 
water) and 3. Food industries (milk and the dairy product-
Industrial Estate) of Tehran city. 
Proper clinical specimens (urine, blood, wound and 
hospital area swabs), Milk and dairy samples (Swabs 
from all the equipment in the production line, before and 
after pasteurization) and river water samples (sampling 
depth	profile	is	12-25	cm	from	the	surface)	were	collected	
and appropriately transported to microbial laboratory 
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for isolation on Sheep Blood agar aerobic cultures, and 
biochemical	 identification	 of	 enterococci.	 Membrane	
filtration	technique	were	used	on	various	sample	dilutions	
to	 achieve	 isolated	 colonies	 (0.45	 µm	membrane	 filter,	
Millipore Corporation, Bedford, MA, USA).
Isolation/identification of enterococci
162 of E. faecium	 isolates	 were	 identified	 from	 737	
different samples of all three origins. The non-hemolytic 
streptococci-like colonies (0.5–1 mm size) of enterococci 
were isolated on Blood agar plate and small dark-red 
magenta colonies were seen on MacConkey agar. The 
enterococci	 colonies	 were	 then	 confirmed	 by	 positive	
gram stain, growth in 6.5% NaCl broth, negative 
catalase test, positive bile-aesculin (bile insolubility) 
test,	and	Enterococcus	species	were	identified	by	special	
fermentation reactions of sugar (glucose, lactose, 
mannitol, sorbitol, and arabinose) (Lee, 1972; Gardini et 
al., 2001; Michaux et al., 2011).
Antibiotic susceptibility test
The vancomycin susceptibility of enterococci isolates 
were	 confirmed	 using	 Laboratory	 Standards	 Institute	
(CLSI) disk diffusion method on Mueller-Hinton 2% 
NaCl with 30µg vancomycin disks (Mast, Merseyside, 
and U.K) and with 35°C for 24 hours incubation condition. 
Zone	diameter	(ZD)	of	inhibition	≥17mm,	15-16mm,	≤14	
mm	or	less	defined	as	susceptible,	intermediate-resistant	
and full-resistant to vancomycin (Jorgensen and Turnidge, 
2015). The vancomycin MIC was determined by the broth 
macro dilution method based on Clinical and Laboratory 
Standards Institute (CLSI) criteria (Dudley et al., 2013). 
Briefly,	 vancomycin	 serial	 dilution	 was	 performed	
in Mueller Hinton broth tubes with the starting bacterial 
density of 5×106 CFU/mL. The tubes were then incubated 
at	 37	 °C	 for	 18	 h	 and	 the	MIC	was	 defined	 by	 lowest	
concentration of antibiotic with no visible bacterial 
growth. Finally, E. faecium isolates were considered as 
susceptible, intermediate-resistant, and full-resistant to 
vancomycin when the MIC was equal to 4 µg/mL, 8- 
16µg/mL	and	≥32	µg/mL,	respectively.	The	controls	for	
vancomycin sensitive enterococci (VSE) and vancomycin 
resistance species were E. faecalis ATCC 51299 and 
E faecalis ATCC 29212 (BD-BBL™ Sensi-Disc™ 
Antimicrobial Susceptibility).
DNA Extraction
All the resistance and sensitive isolates were investigated 
for vancomycin resistance genes. DNA was extracted 
by	 Genomic	 DNA	 Purification	 kit	 protocol	 (#k0512,	
Fermentas,	Thermo	Fisher	Scientific).	Briefly,	enterococci	
cells were grown in LB medium for 24 h. The cultures 
were harvested at 5000 g for 10 min. Then, 10-20 mg 
of bacterial cells were re-suspended to a 1.5-mL screw-
capped	micro	 tube	 containing	 200	μL	of	TE	buffer	 (10	
mM	Tris-HCI,	1	mM	EDTA).	Then	a	mixture	of	200	μL	
of	previous	sample	with	400	μL	lysis	buffer	incubated	at	
65° C for 5 min. DNA was directly extracted from the 
sample	by	adding	600	μL	of	chloroform	and	mixing	for	
3-5 min. The samples for 2 min with 10,000 g (4°C) were 
centrifuged (Eppendorf 5415R; Hamburg, Germany), 
and the upper aqueous layer was separated and  freshly 
transferred	 to	 	 micro-centrifuge	 tube,	 and	 also	 800	 μL	
prepared precipitation solution was added to the tube. 
Gently, the solution was mixed by several inversions 
at room temperature for 1-2 min, then the sample was 
centrifuged (Eppendorf 5415R) at 10,000 g (4°C) for 2 
min. After decanting the supernatant, DNA pellet was 
dissolved	 in	 100μL	 NaCl	 solution	 by	 gentle	 vortexing.	
For the DNA precipitation, 300 µl of cold ethanol was 
added (10 min at -20°C- 10,000 rpm, 3-4 min). Finally, 




Concentration, Purity Determination and DNA Integrity
DNA concentration was measured spectrophotometrically 
and visually after electrophoresis in agarose gel. 
For spectrophotometric assay of DNA, a UV-visible 
spectrophotometer (Agilent Technologies, Santa 
Clara, USA) was used and wavelengths of 260 and 
280 nm (A260 and A280, respectively) were set for 
Absorbance measurement. The estimation of DNA 
purity was made by absorbance quotient (OD260/
OD280). A ratio of <1.7 indicated protein contamination, 
however a ratio of >1.9 indicated RNA contamination. 
An absorbance value of 1.7 < ratio (R) < 1.9 was 
considered	 to	 be	 purified	 DNA.	 Usually	 100	 ng/µL	 of	
DNA were obtained.By resolving DNA extracts on a 
0.8% agarose gel, the integrity of genomic DNA was 
tested (Gel electrophoresis, Bio-Rad, USA), and then 
the test was completed with ethidium bromide staining. 
Each	 DNA	 sample’s	 molecular	 weight	 was	 identified,	
based on the electrophoretic migration of sample DNA 
compared with a known size marker (Fermentas, Thermo 
Scientific).
Polymerase Chain Reaction for amplification 
Extracted	 DNAs	 were	 further	 amplified	 by	 PCR	 (PCR	
Master	Mix	(2X),	#K0171).	Specific	Primers	gyrA	F[5′-	
GAAATCAGAGAAAACATCCATGATG	3′],	gyrA	R[5′-	
ATATTCGTGGCCATACCTACG	 -3′]	 were	 chosen	 in	
this	study	for	PCR	amplification	of	 the	539	bp		product	
containing Ser83 region of gyrA gene of vancomycin 
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resistance and susceptible isolates of E. faecium .
Primer design and Detection of virulence of point 
mutation in gyrA genes at Ser83 by ARMS-PCR (21). All 
the isolates were investigated for vancomycin resistance 
genes.	Identification	of	point	mutation	in	gyrA at position 
83 (serine-to-arginine substitutions) for each isolates of 
VRE and VSE was performed by a separate PCR with 
specific	primers	as	follows;	Two	sets	of	primers,	wild	type,	
and mutant type were designed. Wild type primers for the 
detection of normal DNA of  gyrA Ser83 Region  Forward 
[5′-TAAATACCATCCTCATGGAGACA3′],	gyrA Ser83 
region	 	 	Reverse	 [5′-GTGCTTCGGTATAACGCATA3′],	
and the mutant ones were previously designed by 
Zima gene Co (Iran, Tehran) for gyrA (gyrA-1F	 [5′-	
TAAATACCATCCTCATGGAGACC	 3′]	 and	 gyrA-1R 
(5′-	GTGCTTCGGTATAACGCATA	3′).
The	PCR	assay	was	 carried	out	 in	 a	 25	μL	 solution	
containing 10 mM Tris-HCl (pH = 8.3), 0.2 mM of each 
dNTPs, 1.5 mM MgCl2, 0.5 U TaqDNA polymerase (HT 
Biotechnology, Cambridge, UK), and each primer (40 
pmol). Initial denaturation of PCR cycle was at 95°C 
for	five	minutes,	 then	35	cycles	of	denaturation	at	94°C	
for 50 seconds, and annealing was done at 60°C for 40 
seconds and then followed by extension at 72°C for 50 
seconds,	 with	 a	 final	 extension	 at	 72°C	 for	 5	 minutes.	
An Eppendorf Mastercycler (Eppendorf, Hauppauge, 
NY) was used for PCR. PCR products were visually 
identified	on	horizontal	1.0%	agarose	gels	with	0.5	x	TBE	
buffer, loaded with 5 µL of reaction mix and stained with 
ethidium bromide after electrophoresis. The images were 
captured under U.V. illumination by a video system (Gel 
DOC 1000 system, BioRad).
Statistical analysis
For Statistical analysis tables of frequently were prepared 
and Chi-Square test was used for the relationship between 
variables and difference was considered remarkable 
at p < 0.05 by SPSS software version 19 (Chicago, IL, 
USA).
Results and Discussion
Resistant species identification and isolation
 
According to the biochemical tests, of 737 samples, a 
total of 162 isolates belonged to E. faecium. 59, 18, and 
85 of which were from environment, food industry, and 
hospital respectively. The disk diffusion patterns of E. 
faecium to vancomycin antibiotics are presented in Table 
1. Of 162 isolates of E. faecium, 49 strains were resistant 
to vancomycin by disk diffusion method, but resistance 
of	 41	 strains	 to	 vancomycin	 was	 confirmed	 by	 micro-
dilution broth.
Antimicrobial susceptibility 
Of 162 isolates of E. faecium, resistance of 41 and 
sensitivity of 121 isolates to vancomycin were 
confirmed	by	micro-dilution	broth	method.	So,	antibiotic	
susceptibility test revealed that 11, 7, and 23 isolates 
obtained from environment, food industry, and hospital 
respectively, were vancomycin-resistant (Table 2).
Point Mutation at Ser83 determined by ARMS-PCR 
PCR	technique	was	developed	for	the	identification	of	the	
Ser-to-Arg mutation at amino acid position 86 in the gryA 
of E. faecium	isolates.	The	amplification	of	Isolates	with	
the wild-type amino acid Ser83R were not performed with 
the reverse mutation primer whereas the mutated amino 
acid isolates generated a 152-bp PCR product. Common 
mutations in VRE strains occurred in Ser83 region of 
gyrA gene. The occurrence of nucleic acid alterations in 
these	codons	changed	the	amino	acid	profile	from	Serine	
to Arginine. Forty-one isolates of E. faecium strains were 
examined for the presence of point mutations related to 
vancomycin resistance. The DNA extraction of the152 
bp	fragment	was	confirmed	on	a	1%	agarose	gel	(Fig.	1).	
The	PCR	used	for	gyrA	genes	amplification	by	designed	
primers	 and	 the	 efficacy	of	 the	method	was	determined	
by gel electrophoresis. To identify point mutations, the 
Table 1. Antibiotic resistance behavior of enterococci isolates with disk diffusion.
Antimicrobial agent: vancomycin
ZD of E. faecium  isolates (n=162)
≥ 17 mm 15-16 mm ≤ 14 mm
Sources S* I* R*
Environment 47 0 14
Food industrials 10 0 10
Hospitals 56 0 25
* S: susceptible; I: intermediate-resistant; R: full-resistant
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PCR samples were then analyzed for detection of point 
mutations at Ser83 position of gyrA. The results showed 
that among the 41 vancomycin resistance isolates, 32 VRE 
strains (78%) carried the point mutation at Ser83 position 
of gyrA gene. 9 VRE isolates (22%) had no mutation in 
the sequence areas examined (Fig. 2).
Statistical analysis
Using	SPSS	software,	there	were	significant	correlations	
between the disk diffusion agar and broth micro serial 
dilution methods for vancomycin antibiotic (p ≤	0.001)	
and between ARMS-PCR and MIC for vancomycin 
results (p ≤	0.001)	in	strains	of	E. faecium.
Conclusion
Over the past two decades, enterococci have become 
significantly	 important	 nosocomial	 bacteria	 and	 major	
healthcare-related urinary tract pathogens (Makino et al., 
1986; Huycke et al., 1998; Sood et al., 2008; Fisher and 
Phillips, 2009). These bacteria are increasingly resistant 
to a large number of antimicrobial agents and have the 
potency to rapidly acquire new resistance traits (Huycke 
et al., 1998; Fisher and Phillips, 2009; Rathnayake et al., 
2011; Teymournejad et al., 2011). Vancomycin resistance 
enterococci were isolated in New York City in 1989. 
The	first	occurrence	of	VRE	was	reported	in	September	
1989, and resistant strains had been isolated from 360 
samples in at least 38 hospitals, 20 food industrials, and 
16 environments in 1991 (Ballard et al., 2005; Sood et 
al., 2008). VRE strains are resistant to different classes of 
antibiotics simultaneously. Rising high-level resistance to 
penicillin, ampicillin, glycopeptide, and aminoglycosides 
has been demonstrated in recent years, especially in 
vancomycin-resistant E. faecium strains and due to intra- 
and inter hospital spread of this glycopeptides resistant 
Enterococcus faecium many concerns have arisen and 
limited therapeutic options could be found (Meziane-
Cherif et al., 1994; Ballard et al., 2005; Tenover, 2006; 
Nallapareddy et al., 2011). 
Table 2. Results of MIC for vancomycin in E. faecium strains.
Antimicrobial agent 
(vancomycin)
E. faecium  isolates (n= 59) 
Environment
E. faecium  isolates (n=  18) 
Food industries
 E. faecium isolates (n  = 85 ) 
Hospital
Sensitivity Status S* I* R* S* I* R* S* I* R*
MIC (µg/mL) ≥	4 8 - 16 ≤	32 ≥	4 8 - 16 ≤	32 ≥	4 8 - 16 ≤	32
Number 48 - 11 11 - 7 62 - 23
Percent (%) 81 - 19 61 - 39 73 - 27
* S: susceptible; I: intermediate-resistant; R: full-resistant
Figure 1. Agarose gel electrophoresis of PCR products of E. faecium 
strains for the detection of the 539bp fragment. PCR products were 
loaded on 1 % agarose gel.  Lane 1; Molecular weight marker, Lane 2, 
3, 4; samples from environment, industrial and hospital respectively, 
all	samples	were	confirmed	by	the	presence	of	the	539bp	fragment.
Figure 2. Captured image under U.V. illumination by a video system 
(Gel DOC 1000 system, BioRad) of PCR; the152bp fragment for the 
identification	point	mutation	at	Ser83	region	in	vancomycin	resistance	
E. faecium strains. PCR products were loaded on 1 % agarose gel. 
Thermo	Scientific	GeneRuler	100	bp	DNA	Ladder	(lane	1),	sample	1	
with mutation (lane 2), sample 2 with no mutation (lane 3), sample 3 
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The VRE are became increasingly endemic in 
IRAN, with almost 30% of infections; but, the rates of 
VRE in European countries and in the United States, is 
dramatically changing with absence of these species in 
hospital and healthcare acquired infections (Fatholahzadeh 
et al., 2006). 
In the present study, of 737 samples, 162 isolates were 
identified	 as	E. faecium. The prevalence of E. faecium 
strains were reported 22% in three origins in Tehran, 
composing 36%, 11%, and 52% in the environment, food 
industries and hospitals, respectively. 
By using designed primers developed from conserved 
sequence in the gyrA gene, we were able to amplify and 
identify the existence of corresponding point mutation 
Ser83 region of the gyrA gene in the strains which were 
isolated. The ARMS-PCR results showed among the 41 
vancomycin resistance isolates, 32 VRE strains (78%) 
carried the point mutation at Ser83 position of gyrA 
gene	which	was	 significantly	 correlated	with	 the	MICs.	
Ser-83 in the gyrA seems to play an important role in the 
occurrence of resistance to vancomycin in E. faecium and 
it had been showed in the previous study of others. 
Almost about 30 out of 121 strains showed point 
mutation in Ser83, being susceptible to vancomycin, and 
this may suggest that another mechanism may also be 
involved in the mechanism of resistance of E. faecium 
strains. It meant that the mutation may be mostly conducted 
with a second mutation in gyrA or probably a mutation 
in parC. Our statistical data revealed a correlation between 
the number of mutations and vancomycin resistance. 
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